IBD Strong Peer2Peer for Self-Management of Psychological Distress
Not applicable · Testing IBD Strong Peer2Peer and Waitlist control · 1 site · Jennifer Jones
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing IBD Strong Peer2Peer (a behavioral program) and Waitlist control to improve how care is delivered. Condition(s) listed: Inflammatory Bowel Diseases, Ulcerative Colitis and Crohn Disease.
Participants are assigned to groups by chance (randomized).
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 to 99
- Any sex
Some of the main requirements, copied from the record:
- Adult IBD patient (18 years or older)
- In a period of transition (newly diagnosed, transitioning from pediatric to adult care, flaring or changing medications, recently admitted to hospital, or facing the need for surgery)
There are also 4 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 120 participants are expected to take part.
- Start date: 2023-06-01.
- Main results expected around 2027-03 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Canada.
Main thing being measured
- Participant Satisfaction (week 4)
In the researchers’ words
Psychological distress (PD) as a result of inflammatory bowel disease (IBD) is prevalent and associated with worse disease-related outcomes. IBD-associated psychological distress (IBD-PD) is particularly common at initial diagnosis, during disease flares, before surgery, and during transitions of care.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn Disease |
| Lead sponsor | Jennifer Jones |
| Collaborators | Crohn's and Colitis Canada; Nova Scotia Health Authority |
| Enrollment | 120 (estimated) |
| Start date | 2023-06-01 |
| Primary completion (est.) | 2027-03 |
| First posted | 2023-02-10 |
| Last updated | 2026-09-09 |
| Official title | A Randomized, Wait List-Controlled, Clinical Trial of IBD Strong Peer for Self-Management of Psychological Distress by Persons Living With Inflammatory Bowel Diseases (IBD) |
| ClinicalTrials.gov ID | NCT05722236 |
Interventions
- IBD Strong Peer2Peer (Behavioral)
Mentee participants will experience the intervention: this group will partake in peer-led sessions (peer calls) consisting of up to 10 virtual sessions on Zoom lasting approximately 20-30 minutes in duration over eight weeks. Individual peer calls will be unstructured whereby trained mentors (patients with IBD who have undergone training to be a mentor) and mentees will be given the freedom to dis… - Waitlist control (Other)
Wait list controls will be offered participation in the IBD Strong Peer2Peer intervention once post-control outcome measures have been completed.
Full eligibility criteria (from the record)
Inclusion Criteria: * Adult IBD patient (18 years or older) * In a period of transition (newly diagnosed, transitioning from pediatric to adult care, flaring or changing medications, recently admitted to hospital, or facing the need for surgery) Exclusion Criteria: * Screening positive for severe psychological pathology * Do not speak English * Diagnosis of a major comorbid psychiatric condition such as bipolar disorder or schizophrenia, * No access to the internet
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| QEII Health Sciences Centre | Halifax, N.S. | Canada | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.